Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts premature death in acute coronary syndromes.

Simon Kraler Florian A Wenzl Georgios GeorgiopoulosSlayman ObeidLuca LiberaleArnold von EckardsteinOlivier Müller François Mach Lorenz RäberSylvain LosdatMartin Oliver Schmiady Konstantinos StellosKimon StamatelopoulosGiovanni G Camici Annie Srdic Francesco Paneni Alexander Akhmedov Thomas Felix Lüscher

Published in: European heart journal (2022)

Plasma levels of sLOX-1 are increased during ACS and predict fatal events beyond established risk factors. Trajectories of sLOX-1 mirror coronary plaque progression after the index ACS. Soluble LOX-1 is a novel biomarker of coronary plaque vulnerability and progression.

Keyphrases

low density lipoprotein
acute coronary syndrome
coronary artery disease
risk factors
percutaneous coronary intervention
coronary artery
antiplatelet therapy
climate change
depressive symptoms
atrial fibrillation
binding protein
left ventricular